Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Generative AI writes code in seconds, but leaders who can't think like programmers won't go very far. Computational thinking ...

The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark ...

Recursion Pharmaceuticals (RXRX) shares ended the last trading session 8.2% higher at $5.52. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

Abstract: In adversarial environments, unmanned aerial vehicle (UAV) swarms often face challenges such as node failures, battle damage, and strong electromagnetic interference, which may result in ...

A python was found at a Southern California In-N-Out Burger, surprising customers and employees. The snake has since been reunited with the owner after it was taken into the care of the Pasadena ...